UBS analyst Taylor McGinnis downgrades ZoomInfo Technologies (NASDAQ:ZI) from Buy to Neutral and lowers the price target from $34 to $33.
UBS Downgrades ZoomInfo Technologies to Neutral, Lowers Price Target to $33
UBS analyst Taylor McGinnis downgrades ZoomInfo Technologies (NASDAQ:ZI) from Buy to Neutral and lowers the price target from $34 to $33.
Related Posts
Apple, Coinbase Global, Fortinet And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures traded lower this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session.
‘Ex-Disney Exec To Help Saudis Navigate PGA Tour-LIV Golf Merger’ – Sportico
https://www.sportico.com/leagues/golf/2023/pga-tour-liv-golf-merger-saudi-investment-fund-disney-exec-1234726998/ Geoff Morrell, who recently served a short-lived stint as Disney's top spokesperson, has been
Goldman Sachs Initiates Coverage On PTC Therapeutics with Sell Rating, Announces Price Target of $35
Goldman Sachs analyst Paul Choi initiates coverage on PTC Therapeutics (NASDAQ:PTCT) with a Sell rating and announces Price Target of $35.